US Patent Issued to HORIZON THERAPEUTICS IRELAND DAC on July 15 for "Methods for the treatment of thyroid eye disease" (American, Swiss Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,993, issued on July 15, was assigned to HORIZON THERAPEUTICS IRELAND DAC (Dublin).

"Methods for the treatment of thyroid eye disease" was invented by David Madden (Mount Kisco, N.Y.), Kathleen Gabriel (Voorhees, N.J.), Guido Magni (Basel, Switzerland), Richard Woodward (Phoenixville, Pa.), Shao-Lee Lin (Lake Forest, Ill.) and Jeffrey W. Sherman (Lincolnshire, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a method of treating or reducing the severity of thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' ophthalmopathy or orbitopathy (GO), or a symptom or aspect thereof, in subjects...